Breaking News

Daiichi Sankyo Makes Executive Appointments

October 4, 2013

Gormley takes on president, chairman role, Barrett to head Commercial Division

Glenn Gormley, M.D., Ph.D., has been named corporate president and chairman of Daiichi Sankyo, Inc. Dr. Gormley will also continue in his roles as president, Daiichi Sankyo Pharma Development, global head of R&D, and senior executive officer of Daiichi Sankyo, Co. Ltd. 
 
Also, Greg Barrett has been appointed as the new acting head of the Commercial Division of Daiichi Sankyo, Inc. in the U.S. The company’s former president and chief executive officer, and head of its Commercial Division, John Gargiulo, left the company effective October 3, 2013.
 
Mr. Barrett will serve as acting president of Daiichi Sankyo Administrative & Commercial Operations, responsible for leading Daiichi’s U.S. Commercial Division including marketing, sales and supply chain operations. Mr. Barrett most recently served as vice president, Marketing and Managed Markets, at Daiichi Sankyo, Inc. and has been with the company since the late 1990's.

Related Packaging:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks